ARK Innovation ETF
ARK's flagship actively managed innovation fund — the cross-universe comparison point for disruptive-tech exposure.
Fund summary
Strategy
ARKK supplies the broader, cross-sector active ETF comparison for this pilot. Its issuer holdings file overlaps mapped companies in several research areas, so the page exposes the limits of treating a broad innovation label as a single industrial-stack allocation.
Stated focus
Cross-sector disruptive innovation.
Read full strategy
ARK Innovation ETF (ARKK) is the flagship actively managed thematic fund of ARK Investment Management LLC, the firm founded by Cathie Wood, and is issued through the ARK ETF Trust. Unlike a passive index vehicle, ARKK has no benchmark: its managers select a concentrated, cross-sector portfolio of companies they believe sit at the centre of "disruptive innovation" — across genomic, autonomous, and next-generation internet themes. In the PXS map, ARKK serves as the broad, cross-universe comparison point. Its issuer holdings file overlaps mapped companies in several research areas at once, which is exactly why it is valuable: it exposes the limits of treating a broad innovation label as a single industrial-stack allocation. The page shows only direct, issuer-reported positions in companies already covered by PXS, not the complete portfolio, and it is not a recommendation to buy the fund. Coverage is intentionally limited to the mapped subset, and companies outside the research registry are omitted even where they carry large weights in the issuer file. This makes ARKK useful for finding where a published portfolio intersects an existing research question without implying that every constituent is a pure exposure to that question. Layer classifications come from each company's own record, not from the issuer.
Top 10 holdings
As of Oct 26, 2026. Top holdings by weight among U.S.-listed issuers (stockanalysis.com); non-U.S.-listed positions may be omitted. Portfolio weights are not ownership percentages of the companies.
| # | Company | Ticker | Portfolio weight |
|---|---|---|---|
| 1 | TESLA INC Mapped | TSLA | 10.41% |
| 2 | SPACE EXPLORATION TECHN-CL A | SPCX | 6.61% |
| 3 | TEMPUS AI INC-CL A | TEM | 5.32% |
| 4 | CIRCLE INTERNET GROUP INC | CRCL | 5.23% |
| 5 | CRISPR THERAPEUTICS AG Mapped | CRSP | 4.30% |
| 6 | COINBASE GLOBAL INC -CLASS A | COIN | 4.25% |
| 7 | SHOPIFY INC - CLASS A | SHOP | 3.31% |
| 8 | TWIST BIOSCIENCE CORP Mapped | TWST | 3.14% |
| 9 | NVIDIA CORP Mapped | NVDA | 3.05% |
| 10 | ROBINHOOD MARKETS INC - A | HOOD | 3.04% |
Holdings changes
- 2026-10-19: Added GOOG (1.36%)
- 2026-10-26: NET back in top-25 at 1.24% (held 1.29% on 2026-10-14; rank change, not an addition)
Known positions in mapped companies
| Company | Relationship | Portfolio weight | As of | Evidence |
|---|---|---|---|---|
| Meta Platforms, Inc. | Reported holding | 2.26% | Oct 26, 2026 | Source |
| Tesla, Inc. | Reported holding | 10.41% | Oct 26, 2026 | Source |
| TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD | Reported holding | 1.02% | Oct 26, 2026 | Source |
| Rocket Lab | Reported holding | 1.23% | Oct 26, 2026 | Source |
| Twist Bioscience | Reported holding | 3.14% | Oct 26, 2026 | Source |
| Teradyne | Reported holding | 0.54% | Oct 26, 2026 | Source |
| Recursion Pharmaceuticals | Reported holding | 1.46% | Oct 26, 2026 | Source |
| Palantir Technologies | Reported holding | 2.77% | Oct 26, 2026 | Source |
| Pacific Biosciences | Reported holding | 0.46% | Oct 26, 2026 | Source |
| NVIDIA Corporation | Reported holding | 3.05% | Oct 26, 2026 | Source |
| Natera | Reported holding | 1.19% | Oct 26, 2026 | Source |
| Kratos Defense | Reported holding | 1.07% | Oct 26, 2026 | Source |
| Intellia Therapeutics | Reported holding | 2.01% | Oct 26, 2026 | Source |
| Illumina | Reported holding | 0.97% | Oct 26, 2026 | Source |
| Eli Lilly | Reported holding | 0.57% | Oct 26, 2026 | Source |
| CRISPR Therapeutics | Reported holding | 4.30% | Oct 26, 2026 | Source |
| Cloudflare, Inc. | Reported holding | 1.24% | Oct 26, 2026 | Source |
| BWX Technologies | Reported holding | 1.01% | Oct 26, 2026 | Source |
| Broadcom | Reported holding | 1.87% | Oct 26, 2026 | Source |
| Beam Therapeutics | Reported holding | 2.42% | Oct 26, 2026 | Source |
| Amazon | Reported holding | 2.34% | Oct 26, 2026 | Source |
| Advanced Micro Devices, Inc. | Reported holding | 1.74% | Oct 26, 2026 | Source |
| 10x Genomics | Reported holding | 2.61% | Oct 26, 2026 | Source |
Derived exposure
Counts cover distinct mapped companies only. They are not an allocation and do not describe the full portfolio.
Universes
Layers
- AI Factory & Cloud Training Infrastructure4 mapped companies
- Sim-to-Real, Digital Twins & Validation1 mapped company
- Autonomy Software, Fleet Platforms & End Markets2 mapped companies
- Rejuvenate / Repair4 mapped companies
- Actuation & Motion Control1 mapped company
- AI Discover1 mapped company
- Defense Software & Mission Systems1 mapped company
- Read4 mapped companies
- Intervene1 mapped company
- Zero Trust Security1 mapped company
- Grid, Power & Thermal Infrastructure1 mapped company
- Edge Compute & Control Silicon1 mapped company
- Maintain1 mapped company
Timeline
- Oct 31, 2014
ARK Innovation ETF begins operations
Source
Start here
Open questions
- Which changes represent portfolio trading rather than changes to the company mapping?
- How much of the issuer portfolio lies outside the mapped subset shown here?
- Does the next complete issuer file support a comparable refresh with the same identifiers and denominator?